Laboratory studies have confirmed that antibodies stimulated by Pfizer and BioNTech’s COVID-19 vaccine can neutralise the new, more The post Pfizer/BioNTech say COVID-19 vaccine works against...
Researchers are working on a type of vaccine technology using nanoparticles that is less expensive and does not need to be stored at very low temperatures...
Previous infection with the coronavirus may offer less protection against the new variant first identified in South Africa, although scientists are still hopeful that vaccines will...
A 'psychological vaccine' has proven effective in countering belief in COVID-19 conspiracies.
COVID-19 has been found in pets, zoo animals and in a wild mink in Utah. Monitoring wildlife for COVID-19 is important for animals and humans, both...
Credit: ISGlobal/Clínica Universidad de Navarra. A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild...
Measuring mitochondrial DNA could predict who will need ICU care, intubation Credit: WANDY BEATTY One of the most vexing aspects of the COVID-19 pandemic is doctors’...
One Of The Greatest Economic Blunders In History Authored by James Rickards via The Daily Reckoning, The U.S. economy lost 140,000 jobs in December. Only about...
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating The post A new approach to COVID-19 treatment...
J&J has announced early trial results that suggest its single-shot coronavirus vaccine provides a sustained response against the The post J&J single-shot COVID-19 vaccine shows early...
Credit: Ojeda DS et al., 2021, PLOS Pathogens, CC-BY 4.0 Researchers have developed and applied a robust, versatile antibody test to assist health authorities in managing...
Credit: Joshua Brown A novel new study suggests that the behavior public officials are now mandating or recommending unequivocally to slow the spread of surging COVID-19–wearing...
People who have had Covid-19 are highly likely to have immunity to it for at least five months, but there is evidence that those with antibodies...
A team of researchers led by the University of California, Berkeley, and the University of Michigan has discovered an antibody that blocks the spread within the...
In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact The post Nine for 2021: Addressing the pandemic...
Previous COVID-19 infection provides some immunity for at least five months, but people may still carry and transmit The post Study says COVID-19 infection provides immunity,...
The microscopic organisms living in our intestines may influence the severity of Covid-19 and the body's immune response to it, and could account for lingering symptoms,...
BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.
Regeneron Pharmaceuticals has signed an agreement with the U.S. for the additional supply of 1.25 million doses of its antibody cocktail for the use in non-hospitalized...
Using both mouse and human brain tissue, researchers at Yale School of Medicine have discovered that SARS-CoV-2 can directly infect the central nervous system and have...
Method presents the immune system with several different coronaviruses at once Credit: Courtesy of A. Cohen via BioRender The SARS-CoV-2 virus that is causing the COVID-19...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, January 12, 2021–The Academy of Breastfeeding Medicine (ABM) does not recommend cessation of breastfeeding for individuals who...
Drugmaker GSK and Vir Biotechnology will evaluate a second antibody-based treatment in patients with mild to moderate COVID-19
Combination of two molecules simultaneously attacks multiple sites on the surface of the virus Credit: © Volker Lannert/ University of Bonn Antibodies are an important weapon...
Lead candidates described in Science publication Credit: © DiosCURE Therapeutics Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike...
Model predicts transition to endemic and mild Credit: Jennie Lavine What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes...
Biologists used crystallography performed at Berkeley Lab’s Advanced Light Source to reveal the new virus’s unusual protein structure Credit: Marilyn Sargent/Berkeley Lab A team of HIV...
Evidence continues to build for long-lasting immunity to Covid-19 following disease infection, with the publication of a new study showing a durable immune response as far...
Long-term protection will depend on the 'memory response' developed by our immune systems – and the initial signs are promising.